Medication info
Atorba Tablet 20mg (Atorvastatin Calcium Trihydrate)

Atorba Tablet 20mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Poonglim Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906111 · Approved 2019.08.28 · Insurance code 649002150

Summary

Main use
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular disease (including myocardial infarction)
Who uses it
Adults · Children
Adult dosage
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients who require greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily, administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Children's dosage
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Poonglim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular disease (including myocardial infarction)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in adult patients with risk factors for coronary heart disease. It can also reduce the risk of complications such as revascularization procedures or angina. Similar effects are observed in high-risk groups among patients with type 2 diabetes, contributing to the prevention of cardiovascular complications. For patients with existing cardiovascular diseases, it plays a role in reducing the risks associated with myocardial infarction, stroke, angina, and congestive heart failure. Additionally, in the treatment of hyperlipidemia, it lowers total cholesterol and LDL-cholesterol while raising HDL-cholesterol, thereby improving the blood lipid profile when used alongside dietary changes. It is also used in managing familial hypercholesterolemia in pediatric patients. Thus, this medication improves overall cardiovascular health through the prevention and treatment of cardiovascular diseases and the management of hyperlipidemia.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients who require greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily, administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.

Children's dosage

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication has a risk of muscle problems; therefore, if symptoms such as muscle pain or weakness appear, stop use immediately and consult a doctor. This drug should not be used by patients with certain liver diseases or muscle disorders, pregnant or nursing women, children under the age of 10, or patients taking certain medications. Careful use is required in patients with liver dysfunction or heavy alcohol consumption, and regular liver function tests should be conducted. Notify your doctor immediately if symptoms such as muscle pain, fatigue, or fever occur during treatment, and muscle enzyme level tests may be necessary. This medication can interact with other drugs, so it is essential to inform your physician or pharmacist about any other medications you are taking. Special caution is required when taken with specific antibiotics, antifungals, antivirals, grapefruit juice, and dose adjustments may be necessary. Women taking this medication should consult a doctor if planning pregnancy or during pregnancy and practice appropriate contraception. Caution is particularly needed for children and the elderly as the risk of side effects may be higher. There is no specific antidote for overdose, and treatment should be based on symptoms, monitoring liver function and muscle enzyme levels. Store this medication out of reach of children, and keep it in the original container to maintain quality.

Side effects

  • Weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 153 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • throat and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory impairment
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • muscle pain
  • joint pain
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • positive urine leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • voiding urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbance
  • dizziness
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • hypertonia
  • arthritis
  • mucous cystitis
  • tenosynovitis
  • myasthenia gravis
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypothermia
  • hypertriglyceridemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.